NanoViricides Historical Income Statement
| NNVC Stock | USD 1.14 0.02 1.79% |
Historical analysis of NanoViricides income statement accounts such as Total Operating Expenses of 7 M can show how well NanoViricides performed in making a profits. Evaluating NanoViricides income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of NanoViricides's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining NanoViricides latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether NanoViricides is a good buy for the upcoming year.
NanoViricides |
About NanoViricides Income Statement Analysis
NanoViricides Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to NanoViricides shareholders. The income statement also shows NanoViricides investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
NanoViricides Income Statement Chart
NanoViricides Income Statement is one of the three primary financial statements used for reporting NanoViricides's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of NanoViricides revenue and expense. NanoViricides Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, NanoViricides' Cost Of Revenue is projected to increase significantly based on the last few years of reporting. The current year's Net Interest Income is expected to grow to about 428.5 K, whereas Interest Expense is forecasted to decline to 1,025. Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of NanoViricides. It is also known as NanoViricides overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from NanoViricides' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into NanoViricides current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NanoViricides. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. For information on how to trade NanoViricides Stock refer to our How to Trade NanoViricides Stock guide.At present, NanoViricides' Cost Of Revenue is projected to increase significantly based on the last few years of reporting. The current year's Net Interest Income is expected to grow to about 428.5 K, whereas Interest Expense is forecasted to decline to 1,025.
| 2021 | 2022 | 2023 | 2024 (projected) | Reconciled Depreciation | 723.3K | 747.5K | 859.7K | 772.2K | Interest Income | 11.9K | 355.8K | 409.2K | 429.7K |
NanoViricides income statement Correlations
Click cells to compare fundamentals
NanoViricides Account Relationship Matchups
High Positive Relationship
High Negative Relationship
NanoViricides income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Expense | 93.7K | 85.4K | 5.1K | 938.0 | 1.1K | 1.0K | |
| Other Operating Expenses | 8.0M | 8.7M | 8.1M | 8.9M | 10.3M | 7.0M | |
| Operating Income | (8.0M) | (8.7M) | (8.1M) | (8.9M) | (8.0M) | (8.5M) | |
| Ebit | (8.0M) | (8.7M) | (8.1M) | (8.6M) | (7.7M) | (8.1M) | |
| Research Development | 4.7M | 6.1M | 5.8M | 6.4M | 7.4M | 4.2M | |
| Ebitda | (7.4M) | (8.0M) | (7.4M) | (7.8M) | (7.1M) | (7.4M) | |
| Total Operating Expenses | 8.0M | 8.7M | 8.1M | 8.9M | 10.3M | 7.0M | |
| Net Income | (13.4M) | (8.9M) | (8.1M) | (8.6M) | (7.7M) | (8.1M) | |
| Income Tax Expense | (49.0K) | 85.4K | (6.7K) | 355.8K | 320.3K | 304.2K | |
| Depreciation And Amortization | 574.1K | 713.9K | 735.2K | 747.5K | 859.7K | 440.2K | |
| Selling General Administrative | 3.3M | 2.6M | 2.3M | 2.6M | 2.9M | 3.0M | |
| Income Before Tax | (13.4M) | (8.8M) | (8.1M) | (8.6M) | (9.9M) | (10.4M) | |
| Total Other Income Expense Net | (5.5M) | (78.1K) | 6.7K | 354.9K | 319.4K | 303.4K | |
| Net Income From Continuing Ops | (13.4M) | (8.8M) | (8.1M) | (8.6M) | (7.7M) | (8.1M) | |
| Net Income Applicable To Common Shares | (13.4M) | (8.8M) | (8.1M) | (8.6M) | (7.7M) | (8.1M) | |
| Gross Profit | (699.7K) | (704.5K) | (723.3K) | (747.5K) | (672.8K) | (639.1K) | |
| Cost Of Revenue | 699.7K | 704.5K | 723.3K | 747.5K | 859.7K | 902.6K | |
| Net Interest Income | (76.6K) | (76.1K) | 6.7K | 354.9K | 408.1K | 428.5K | |
| Interest Income | 17.1K | 9.3K | 11.9K | 355.8K | 409.2K | 429.7K | |
| Reconciled Depreciation | 699.7K | 704.5K | 723.3K | 747.5K | 859.7K | 772.2K |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards NanoViricides in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, NanoViricides' short interest history, or implied volatility extrapolated from NanoViricides options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NanoViricides. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. For information on how to trade NanoViricides Stock refer to our How to Trade NanoViricides Stock guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for NanoViricides Stock analysis
When running NanoViricides' price analysis, check to measure NanoViricides' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NanoViricides is operating at the current time. Most of NanoViricides' value examination focuses on studying past and present price action to predict the probability of NanoViricides' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NanoViricides' price. Additionally, you may evaluate how the addition of NanoViricides to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Stocks Directory Find actively traded stocks across global markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is NanoViricides' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NanoViricides. If investors know NanoViricides will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NanoViricides listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.80) | Return On Assets (0.36) | Return On Equity (0.58) |
The market value of NanoViricides is measured differently than its book value, which is the value of NanoViricides that is recorded on the company's balance sheet. Investors also form their own opinion of NanoViricides' value that differs from its market value or its book value, called intrinsic value, which is NanoViricides' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NanoViricides' market value can be influenced by many factors that don't directly affect NanoViricides' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NanoViricides' value and its price as these two are different measures arrived at by different means. Investors typically determine if NanoViricides is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NanoViricides' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.